Lentitek

Lentitek is a biotechnology company developing proprietary lentiviral vector manufacturing technology for cell and gene therapy developers.

Its platform uses novel promoter engineering to reduce unwanted payload gene expression in manufacturing cell lines, improving vector yield, quality and potency.

The technology addresses a key cost-of-goods barrier limiting the accessibility of CAR-T and related advanced therapy medicinal products, and is commercialised through a licensed integration model with therapeutic developers and contract manufacturers.